SmallCapReview.com has been a leading site for information on small cap stocks, penny stocks and microcaps since 1999, to receive the free SmallCapReview newsletter and be entered to win a Free iPod Touch visit http://www.smallcapreview.com.
Korn/Ferry International (NYSE: KFY) $14.94. Today announced Q1 FY'11 diluted earnings per share of $0.24 compared to diluted loss per share of $0.33 in Q1 FY'10. Excluding restructuring charges of $18.2 million, diluted loss per share in Q1 FY'10 was $0.05.
"With our fifth consecutive sequential fee revenue increase and a year-over-year improvement of fifty percent, I am enormously proud of our organization and pleased with the results of the quarter," said Gary D. Burnison, CEO of Korn/Ferry International. "We have outperformed a seemingly directionless economy. For Korn/Ferry, the whole is truly stronger than the sum of our parts. It is our differentiation which has enabled us to outperform the industry. Our outsourcing and leadership businesses now comprise over 25% of our overall business. The combination of our complementary new offerings to our flagship executive recruiting business and our relentless focus on clients is providing the fortitude necessary for our continued success."
What They Do: Korn/Ferry International is a premier global provider of talent management solutions
Maxwell Technologies, ((Nasdaq: MXWL) $12.35. Today announced that it has delivered BOOSTCAP ultracapacitor cells and multi-cell modules for more than 1,000 hybrid transit bus drive systems through the first three quarters of 2010, and sees continuing strong demand going forward.
Ultracapacitor-based energy storage systems are highly efficient in absorbing recuperative braking energy and delivering stored energy to zero-emission electric motors for acceleration in electric and hybrid internal combustion/electric vehicles. Ultracapacitors operate normally at temperatures as low as -40 C, and are designed to perform reliably through one million or more deep discharge cycles, or about 10 years of operational life for most vehicles.
What They Do: Maxwell is a leading developer and manufacturer of innovative, cost-effective energy storage and power delivery solutions.
CombinatoRx (Nasdaq: ZLCS) $1.33. Today announced that it has changed its name to Zalicus Inc. The company will begin trading under the new ticker symbol ZLCS on the NASDAQ Global Market at market open on September 9, 2010. The company also received a new CUSIP number (98887C 105) for its common stock. CombinatoRx merged with Neuromed Pharmaceuticals in December 2009 and has chosen a new name to highlight the assets, expertise and focus of the combined company.
“We have evolved into a new, multidimensional company following the completed integration of Neuromed and CombinatoRx and the commercial launch of Exalgo by Covidien. Under the Zalicus name we look forward to bringing innovative treatments to patients using the assets, expertise and focus of the merged company,” explained Mark H.N. Corrigan, MD, President and CEO of Zalicus. "Our new name reflects the Company’s transformation into a biopharmaceutical company with product revenues, two powerful and differentiated drug discovery platforms, a pipeline of product candidates and proven drug development expertise focused on the treatment of pain and inflammation.”
What They Do: Zalicus is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases.
About SmallCapReview
Copyright SmallCapReview. SmallCapReview.com is a leading site for news on small-caps, penny stocks and microcaps. SmallCapReview has built a loyal opt-in following for their investor products by providing a newsletter at no cost, sent to subscribers, highlighting select stocks in play, to register visit http://www.smallcapreview.com.
